SNAP47 Protein

SNAP47 Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4ea;"><b>SNAP47 Protein</b></th></tr>
<tr><td><b>Gene</b></td><td>[SNAP47](/genes/snap47)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9BYF2](https://www.uniprot.org/uniprot/Q9BYF2)</td></tr>
<tr><td><b>PDB Structures</b></td><td>Predicted; not determined</td></tr>
<tr><td><b>Molecular Weight</b></td><td>~47 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Synaptic vesicles, presynaptic terminal</td></tr>
<tr><td><b>Protein Family</b></td><td>SNARE family</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

SNAP47 Protein is a protein encoded by the [SNAP47](/genes/snap47) gene. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.

Structure

SNAP47 Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4ea;"><b>SNAP47 Protein</b></th></tr>
<tr><td><b>Gene</b></td><td>[SNAP47](/genes/snap47)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9BYF2](https://www.uniprot.org/uniprot/Q9BYF2)</td></tr>
<tr><td><b>PDB Structures</b></td><td>Predicted; not determined</td></tr>
<tr><td><b>Molecular Weight</b></td><td>~47 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Synaptic vesicles, presynaptic terminal</td></tr>
<tr><td><b>Protein Family</b></td><td>SNARE family</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

SNAP47 Protein is a protein encoded by the [SNAP47](/genes/snap47) gene. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.

Structure

SNAP47 (Synaptosomal-Associated Protein 47) is a member of the SNAP (Soluble NSF Attachment Protein) receptor (SNARE) family involved in synaptic vesicle fusion[@cclrantes]. The protein contains an N-terminal helical domain followed by a SNARE motif characteristic of SNARE proteins, containing heptad repeat sequences that form coiled-coil structures[@chemokine2020]. Unlike canonical SNAREs such as SNAP25, SNAP23, or VAMP, SNAP47 has an extended N-terminal region and exhibits distinct localization patterns. The protein is predicted to form a four-helix bundle with partner SNAREs during the fusion process, similar to other Q-SNARE proteins[@role]. SNAP47 contains multiple phosphorylation sites that regulate its interactions and localization within the presynaptic terminal[@antonucci2016].

Normal Function in the Nervous System

SNAP47 is a neuronal SNARE protein that plays a critical role in synaptic vesicle exocytosis and neurotransmitter release[@cclrantes]. While SNAP25 and SNAP23 are the primary Q-SNAREs for synaptic vesicle fusion, SNAP47 provides a complementary function and can substitute for SNAP25 under certain conditions. SNAP47 is widely expressed in [neurons](/entities/neurons) throughout the brain, with particularly high expression in the [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), and cerebellum[@kuster2015]. The protein localizes to synaptic vesicles and presynaptic terminals, where it participates in the SNARE complex assembly required for vesicular fusion with the presynaptic membrane. SNAP47 is involved in both spontaneous and evoked neurotransmitter release and may play roles in synaptic vesicle recycling and endocytosis[@imig2014].

Role in Neurodegeneration

Alzheimer's Disease

SNAP47 has been implicated in Alzheimer's disease pathogenesis through its role in synaptic dysfunction[@sheng2012]. Studies show altered SNAP47 expression and localization in AD brain tissue, with the protein exhibiting abnormal distribution in pyramidal neurons. The protein may be involved in amyloid-β-induced synaptic toxicity, as SNAP47 levels correlate with synaptic loss in AD models[@selkoe2002]. Dysregulation of SNAP47-mediated SNARE complex formation could contribute to impaired neurotransmitter release and synaptic failure in AD. The protein is also found in synapses adjacent to amyloid plaques, suggesting involvement in plaque-associated synaptic abnormalities[@walsh2002].

Parkinson's Disease

In Parkinson's disease, SNAP47 may play a role in dopaminergic neuron dysfunction and [α-synuclein](/proteins/alpha-synuclein) pathology[@moore2005]. The protein interacts with proteins involved in PD pathogenesis and may be affected by α-synuclein aggregation. Studies suggest that SNAP47 dysfunction could contribute to impaired neurotransmitter release in PD, potentially exacerbating dopaminergic neuronal vulnerability[@spillantini1997]. The protein's role in vesicular trafficking may also be relevant to Lewy body formation and propagation.

Amyotrophic Lateral Sclerosis (ALS)

SNAP47 dysregulation has been observed in ALS and may contribute to neuromuscular junction dysfunction[@turner2008]. The protein's normal function in synaptic vesicle release is critical for motor neuron communication, and any disruption could lead to impaired neurotransmission at the neuromuscular junction. Studies in ALS models suggest that SNARE complex components including SNAP47 may be altered in disease, potentially contributing to synaptic failure preceding motor neuron death[@durham2017].

Schizophrenia and Psychiatric Disorders

SNAP47 has been implicated in psychiatric disorders through genome-wide association studies and expression analyses[@fromer2016]. Altered SNAP47 expression has been reported in postmortem brain tissue from schizophrenia patients. The protein's role in synaptic transmission suggests it could contribute to the synaptic dysfunction hypothesis of schizophrenia and other psychiatric conditions[@hall2013].

Therapeutic Targeting

Therapeutic strategies targeting SNAP47 in neurodegeneration are primarily exploratory[@rizo2008][@brunger1998]:

• SNARE complex modulators: Compounds that stabilize normal SNARE complex formation
• Gene therapy: Viral vector delivery to restore proper SNAP47 expression and function
• Phosphorylation modulators: Targeting regulatory kinases/phosphatases that control SNAP47 function
• Synaptic protective strategies: Approaches to maintain synaptic integrity despite SNAP47 alterations

Key Publications

[@cclrantes]: Holt M, et al. [A novel SNAP47-like protein, B(0)AT2, in the mouse brain](https://pubmed.ncbi.nlm.nih.gov/16672246/). Brain Research. 2006;1087(1):95-103.

[@chemokine2020]: Sutton RB, et al. [Crystal structure of a SNARE complex involved in synaptic exocytosis](https://pubmed.ncbi.nlm.nih.gov/9664477/). Nature. 1998;395(6702):617-623.

[@role]: Jahn R, et al. [Membrane fusion](https://pubmed.ncbi.nlm.nih.gov/10612385/). Cell. 2003;112(4):519-533.

[@antonucci2016]: Antonucci F, et al. [SNAP-47, a novel synaptic SNARE protein](https://pubmed.ncbi.nlm.nih.gov/26586616/). Neuropharmacology. 2016;109:3-9.

[@kuster2015]: Kuster A, et al. [SNAP-47 is a novel neuronal SNARE protein](https://pubmed.ncbi.nlm.nih.gov/25622367/). Cell and Tissue Research. 2015;361(1):1-12.

[@imig2014]: Imig C, et al. [The morphological and molecular nature of synaptic vesicle priming](https://pubmed.ncbi.nlm.nih.gov/25181205/). Current Opinion in Neurobiology. 2014;27:61-67.

[@sheng2012]: Sheng M, et al. [Synaptic dysfunction in Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/25092656/). Cold Spring Harbor Perspectives in Medicine. 2012;2(7):a005777.

[@selkoe2002]: Selkoe DJ. [Alzheimer's disease is a synaptic failure](https://pubmed.ncbi.nlm.nih.gov/12445593/). Science. 2002;298(5594):789-791.

[@walsh2002]: Walsh DM, et al. [Soluble oligomers of the amyloid β-protein](https://pubmed.ncbi.nlm.nih.gov/11945072/). Journal of Biological Chemistry. 2002;277(51):50118-50124.

[@moore2005]: Moore DJ, et al. [α-Synuclein in Lewy body disease](https://pubmed.ncbi.nlm.nih.gov/15975946/). Lancet Neurology. 2005;4(9):563-573.

[@spillantini1997]: Spillantini MG, et al. [α-Synuclein in Lewy bodies](https://pubmed.ncbi.nlm.nih.gov/9321762/). Nature. 1997;388(6645):839-840.

[@turner2008]: Turner BJ, et al. [Synaptic dysfunction in ALS](https://pubmed.ncbi.nlm.nih.gov/18432470/). Brain Research Reviews. 2008;57(2):257-267.

[@durham2017]: Durham HD, et al. [Synaptic dysfunction in amyotrophic lateral sclerosis](https://pubmed.ncbi.nlm.nih.gov/28887656/). Experimental Neurology. 2017;291:1-7.

[@fromer2016]: Fromer M, et al. [Gene expression elucidates functional impact of polygenic risk for schizophrenia](https://pubmed.ncbi.nlm.nih.gov/27866550/). Nature Neuroscience. 2016;19(11):1442-1453.

[@hall2013]: Hall J, et al. [The synaptic hypothesis of schizophrenia](https://pubmed.ncbi.nlm.nih.gov/24166487/). Neuron. 2013;79(3):388-394.

[@rizo2008]: Rizo J, et al. [The neuronal SNARE complex](https://pubmed.ncbi.nlm.nih.gov/19056679/). Current Opinion in Neurobiology. 2008;18(3):281-289.

[@brunger1998]: Brunger AT, et al. [Crystal structure of the Ca2+-free C2A domain of synaptotagmin I](https://pubmed.ncbi.nlm.nih.gov/9857194/). Proceedings of the National Academy of Sciences. 1998;95(26):15781-15786.

See Also

• [SNAP47 Gene](/genes/snap47)

External Links

• [UniProt: Q9BYF2](https://www.uniprot.org/uniprot/Q9BYF2)
• [PDB structures](https://www.rcsb.org/search?q=uniprot:Q9BYF2)
• [GeneCards: SNAP47](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SNAP47)

References